Splenic vein thrombosis screening: Difference between revisions
Sunny Kumar (talk | contribs) No edit summary |
Sunny Kumar (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} | {{CMG}} ; {{AE}} {{Vbe}} | ||
==Overview== | ==Overview== | ||
There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein]] [[thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]]. <ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref><ref name="pmid26080307">{{cite journal| author=Valla D| title=Splanchnic Vein Thrombosis. | journal=Semin Thromb Hemost | year= 2015 | volume= 41 | issue= 5 | pages= 494-502 | pmid=26080307 | doi=10.1055/s-0035-1550439 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26080307 }}</ref> | There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein]] [[thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]]. <ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref><ref name="pmid26080307">{{cite journal| author=Valla D| title=Splanchnic Vein Thrombosis. | journal=Semin Thromb Hemost | year= 2015 | volume= 41 | issue= 5 | pages= 494-502 | pmid=26080307 | doi=10.1055/s-0035-1550439 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26080307 }}</ref><ref name="pmid29211374">{{cite journal| author=Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M et al.| title=[Splanchnic vein thrombosis]. | journal=Rev Med Suisse | year= 2017 | volume= 13 | issue= 586 | pages= 2138-2143 | pmid=29211374 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211374 }}</ref> | ||
== Screening== | == Screening== | ||
Revision as of 16:00, 5 February 2018
|
Splenic vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Splenic vein thrombosis screening On the Web |
|
American Roentgen Ray Society Images of Splenic vein thrombosis screening |
|
Risk calculators and risk factors for Splenic vein thrombosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly. [1][2][3]
Screening
There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly. [1]
References
- ↑ 1.0 1.1 Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O (2017). "[Routine screening of splenic or portal vein thrombosis after splenectomy]". Rev Med Interne (in French). 38 (1): 3–7. doi:10.1016/j.revmed.2016.08.003. PMID 27639911.
- ↑ Valla D (2015). "Splanchnic Vein Thrombosis". Semin Thromb Hemost. 41 (5): 494–502. doi:10.1055/s-0035-1550439. PMID 26080307.
- ↑ Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). "[Splanchnic vein thrombosis]". Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.